Literature DB >> 24145033

Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.

Petr Dmitriev1, Luiza Stankevicins, Eugenie Ansseau, Andrei Petrov, Ana Barat, Philippe Dessen, Thomas Robert, Ahmed Turki, Vladimir Lazar, Emmanuel Labourer, Alexandra Belayew, Gilles Carnac, Dalila Laoudj-Chenivesse, Marc Lipinski, Yegor S Vassetzky.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant hereditary neuromuscular disorder linked to the deletion of an integral number of 3.3-kb-long macrosatellite repeats (D4Z4) within the subtelomeric region of chromosome 4q. Most genes identified in this region are overexpressed in FSHD myoblasts, including the double homeobox genes DUX4 and DUX4c. We have carried out a simultaneous miRNome/transcriptome analysis of FSHD and control primary myoblasts. Of 365 microRNAs (miRNAs) analyzed in this study, 29 were found to be differentially expressed between FSHD and normal myoblasts. Twenty-one microRNAs (miR-1, miR-7, miR-15a, miR-22, miR-30e, miR-32, miR-107, miR-133a, miR-133b, miR-139, miR-152, miR-206, miR-223, miR-302b, miR-331, miR-362, miR-365, miR-382, miR-496, miR-532, miR-654, and miR-660) were up-regulated, and eight were down-regulated (miR-15b, miR-20b, miR-21, miR-25, miR-100, miR-155, miR-345, and miR-594). Twelve of the miRNAs up-regulated in FHSD were also up-regulated in the cells ectopically expressing DUX4c, suggesting that this gene could regulate miRNA gene transcription. The myogenic miRNAs miR-1, miR-133a, miR-133b, and miR-206 were highly expressed in FSHD myoblasts, which nonetheless did not prematurely enter myogenic differentiation. This could be accounted for by the fact that in FSHD myoblasts, functionally important target genes, including cell cycle, DNA damage, and ubiquitination-related genes, escape myogenic microRNA-induced repression.

Entities:  

Keywords:  Facioscapulohumeral Dystrophy; Genetic Diseases; MicroRNA; Muscular Dystrophy; Transcription; Transcription Regulation

Mesh:

Substances:

Year:  2013        PMID: 24145033      PMCID: PMC3853252          DOI: 10.1074/jbc.M113.504522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

2.  A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes.

Authors:  Kevin C Miranda; Tien Huynh; Yvonne Tay; Yen-Sin Ang; Wai-Leong Tam; Andrew M Thomson; Bing Lim; Isidore Rigoutsos
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

3.  DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation.

Authors:  Darko Bosnakovski; Sarah Lamb; Tugba Simsek; Zhaohui Xu; Alexandra Belayew; Rita Perlingeiro; Michael Kyba
Journal:  Exp Neurol       Date:  2008-08-06       Impact factor: 5.330

4.  Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Kristiaan J van der Gaag; Sofia Zuniga; Rune R Frants; Peter de Knijff; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

5.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

6.  Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.

Authors:  Lauren Snider; Linda N Geng; Richard J L F Lemmers; Michael Kyba; Carol B Ware; Angelique M Nelson; Rabi Tawil; Galina N Filippova; Silvère M van der Maarel; Stephen J Tapscott; Daniel G Miller
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

7.  The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway.

Authors:  Aurélie Granjon; Marie-Paule Gustin; Jennifer Rieusset; Etienne Lefai; Emmanuelle Meugnier; Isabelle Güller; Catherine Cerutti; Christian Paultre; Emmanuel Disse; Rémi Rabasa-Lhoret; Martine Laville; Hubert Vidal; Sophie Rome
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

8.  DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.

Authors:  Eugénie Ansseau; Dalila Laoudj-Chenivesse; Aline Marcowycz; Alexandra Tassin; Céline Vanderplanck; Sébastien Sauvage; Marietta Barro; Isabelle Mahieu; Axelle Leroy; India Leclercq; Véronique Mainfroid; Denise Figlewicz; Vincent Mouly; Gillian Butler-Browne; Alexandra Belayew; Frédérique Coppée
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

9.  Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.

Authors:  Marietta Barro; Gilles Carnac; Sébastien Flavier; Jacques Mercier; Yegor Vassetzky; Dalila Laoudj-Chenivesse
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

10.  Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.

Authors:  Beatrice Bodega; Gabriella Di Capua Ramirez; Florian Grasser; Stefania Cheli; Silvia Brunelli; Marina Mora; Raffaella Meneveri; Anna Marozzi; Stefan Mueller; Elena Battaglioli; Enrico Ginelli
Journal:  BMC Biol       Date:  2009-07-16       Impact factor: 7.431

View more
  32 in total

1.  miR-660 promotes liver cancer cell proliferation by targeting PPP2R2A.

Authors:  Yaozhen Pan; Lei Zhan; Ling Chen; Liwen Chen; Chengyi Sun
Journal:  Exp Ther Med       Date:  2021-04-25       Impact factor: 2.447

Review 2.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

3.  Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures.

Authors:  Jong-Won Lim; Chao-Jen Wong; Zizhen Yao; Rabi Tawil; Silvère M van der Maarel; Daniel G Miller; Stephen J Tapscott; Galina N Filippova
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

4.  Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.

Authors:  Yara Bou Saada; Carla Dib; Petr Dmitriev; Aline Hamade; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Yegor S Vassetzky
Journal:  Histochem Cell Biol       Date:  2016-02-09       Impact factor: 4.304

Review 5.  Emerging preclinical animal models for FSHD.

Authors:  Angela Lek; Fedik Rahimov; Peter L Jones; Louis M Kunkel
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

6.  MiR-382 Functions on the Regulation of Melanogenesis via Targeting dct in Rainbow Trout (Oncorhynchus mykiss).

Authors:  Shenji Wu; Jinqiang Huang; Yongjuan Li; Zhe Liu; Lu Zhao
Journal:  Mar Biotechnol (NY)       Date:  2022-07-27       Impact factor: 3.727

Review 7.  The role of microRNAs in skeletal muscle health and disease.

Authors:  Tyler J Kirby; Thomas Chaillou; John J McCarthy
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

Review 8.  Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals.

Authors:  Ceren Hangül; Sibel Berker Karaüzüm; Esra Küpeli Akkol; Devrim Demir-Dora; Zafer Çetin; Eyüp İlker Saygılı; Gökhan Evcili; Eduardo Sobarzo-Sánchez
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

9.  MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition.

Authors:  Ahmed S Bayoumi; Jian-Peng Teoh; Tatsuya Aonuma; Zhize Yuan; Xiaofen Ruan; Yaoliang Tang; Huabo Su; Neal L Weintraub; Il-Man Kim
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

Review 10.  Non-coding RNAs in muscle differentiation and musculoskeletal disease.

Authors:  Monica Ballarino; Mariangela Morlando; Alessandro Fatica; Irene Bozzoni
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.